Inflammatory Myofibroblastic Tumor
📧 Sign up to get email alerts when something new happens for Inflammatory Myofibroblastic Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial update indicates brigatinib is currently recruiting pediatric and young adult patients with ALK-positive Anaplast…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: CREATE: Cross-tumoral Phase 2 With Crizotinib [Phase 2]
Phase 2 cross-tumor trial evaluating crizotinib in multiple locally advanced or metastatic cancers; study completed.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors [Phase 2, Phase 3]
Phase 2/3 study of crizotinib in children and adolescents with inflammatory myofibroblastic tumor is underway, status currently unknown.